Every recall we track for Fagron Compounding Services — 10 in all — plus the complaints and injury reports the public filed about them.
Fagron recalls specific Vancomycin HCL injections due to risk of blue break-off part detaching during use, potentially causing infection. Affected lots and expiration dates listed.
Fagron recalls norepinephrine injections with potential blue break-off part that could detach during use. Stop using affected lots before 2026.
Fagron recalls norepinephrine injections with a risk of blue break-off part detaching during use. Affected lots have specific expiration dates and NDC numbers.
Fagron recalls specific lots of Vancomycin HCI injection due to risk of blue break-off part detaching during use, potentially causing contamination.
Fagron recalls specific Vancomycin HCI injections due to risk of blue break-off part detaching from administration port, potentially causing infection. Affected lots and expiration dates listed.
Fagron recalls 0.5mL single-use eye drop solution due to incorrect product formulation. This may affect safety if used improperly. Contact Fagron for details.
Fagron recalls specific lots of bevacizumab (Avastin) injections due to lack of sterility assurance. Affected patients should contact their healthcare provider for guidance.
Fagron recalls fentanyl citrate IV bags due to lack of assurance of sterility. This could cause infections if used improperly. Affected units have specific lot numbers and expiration dates.
Fagron recalls lidocaine injections with lot numbers C274-000037397 to C274-000037400 due to lack of sterility assurance. These products were sold in Wichita, KS, expiring October 2024.